Not Yet Recruiting
Tislelizumab in Combination With Bevacizumab and Capecitabine in Advanced Solid Tumors With Evaluation in Immunotherapy-Resistant and Central Nervous System Disease
NCT07681297
- Conditions
- Advanced Solid Tumor Cancer, Breast Cancer, Breast Diseases, +10 more
- Locations
-
- National University Cancer Institute, Singapore, National University Health System Singapore